 | | | | |
| |  | |  | | |
| |  |
| PRIME NEWS |  |
|
 |
|
|
EnzymeRx, a clinical-stage biotechnology company has announced completion of the enrollment of its first clinical trial of pegsitacase (formerly called Uricase PEG 20), and the recent launch of a second clinical study
|
|
|
|
|
|
|
|
|
Japan's Astellas Pharma has launched a hostile bid to acquire OSI Pharmaceuticals, a Nasdaq listed developer of molecular targeted therapies for oncology, diabetes and obesity
|
|
|
|
|
|
|
| | |
Read the latest biotechnology news & articles, trends and analysis, biotechnology business and investment opportunities, research & development breakthroughs, bio technology product features, event listings, job postings and market research studies on bio technology in BioSpectrum Asia.
| | | | |  | |  | | |
|
|
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
|
Novartis offers to buy Transgene drug options for $995 mn
|
|
| Transgene has signed an exclusive option agreement with Novartis for the development and commercialization of Transgene's targeted immunotherapy product, TG4010 (MVA-MUC1-IL2), for the first-line treatment of non-small cell lung cancer |
|
|
|
|
|
International Symposium on Alcohol fuels starts in Delhi
|
|
| The 34th edition of the International Symposium on Alcohol Fuels (ISAF XVIII) is being held in New Delhi between March 9-12, 2010. The main theme of the event is 'Innovation for Local and Global Sustainability of Alcohol Fuels' |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
FEATURES |
|
|
|
|
|
|
Neurodegenerative Market: $30 billion potential
|
|
| What was thought to be the diseases of the European and American ancestry, neurodegenerative diseases are now becoming prevalent amongst Asian population as well. This has got the attention of drug developers in Asia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
EmTech India 2010 inaugurated
|
|
| The second edition of the EmTech India 2010 was inaugurated today in Bangalore. The first edition of this premier event happened in New Delhi last year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
|
|
FDA approves Rituxan to treat CLL
|
|
| The US Food and Drug Administration approved Rituxan (rituximab) to treat certain patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow cancer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
Waters introduces Viridis SFC Columns
|
|
| Waters Corporation introduced Viridis Supercritical Fluid Chromatography (SFC) columns, a new family of analytical and preparative supercritical fluid chromatography (SFC) columns. Waters new Viridis SFC columns were developed to give laboratories |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRENDS & ANALYSIS |
|
|
|
|
Global biochip markets to increase to $6 billion by 2014
|
|
| According to a new technical market research report from BCC Research, the global market value for biochip products is an estimated $2.6 billion in 2009, but is expected to increase to nearly $6 billion in 2014, for a 5-year CAGR of 17.7% |
|
|
|
|
|
Global vaccine market to see growth of 13% during 2009-12
|
|
| Vaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry. With a projected CAGR of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy area. The US and Europe represent 2 largest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
